Top News
Extended Bisphosphonate Treatment Does Not Improve Survival in High-Risk Early Breast Cancer
SBRT Proved Better Than EBRT for Alleviating Pain in Cancer Patients With Spinal Metastases
Carfilzomib Therapies Effective for Patients With Relapsed/Refractory Multiple Myeloma
Keytruda Plus Lenvima Gets Full Approval for Advanced Endometrial Cancer
Germline Testing Reveals Actionable Mutations in Advanced Cancers
Cost of Care a Substantial Burden for Fee-for-Service Medicare Recipients With Multiple Myeloma
Regimen Deemed Safe, Effective as Bridge to Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma
Removing a Large Uterus via Minimally Invasive Surgery Linked to Local Recurrence of High-Grade Endometrial Cancer
Better Patient-Reported Outcomes With Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma
Local Resection Is ‘Sufficient’ for Parathyroid Carcinoma
Study Supports FOLFOX as Standard Second-Line Treatment for Advanced Biliary Tract Cancer
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
How to Prevent COVID-19 Vaccination From Interfering With Cancer Imaging
Education, communication, and coordination are key. -
No Survival Benefit With Pembrolizumab in Advanced Urothelial Carcinoma
Platinum-based chemotherapy should remain the standard of care, according to researchers. -
Seroconversion After COVID-19 Vaccination Lower With Hematologic Malignancies, Lowest With MM
A single-center study found anti-COVID-19 protection lowest in patients with MM at 2 weeks after their second BNT162b2 mRNA shot than did patients with myeloproliferative malignancies, and was highest in older patients without cancer. -
Overcoming Obstacles to Health Equity in Breast Cancer Prevention and Control
The current scientific evidence may not be generalizable to underrepresented groups. -
BRAF MAF May Predict Survival in Metastatic CRC
When researchers combined clinical features with BRAF mutant allele fraction, patients could be divided into 3 risk groups that were significantly associated with survival. -
Platinum Chemo Appears to Cause Clonal Expansion, Myeloid Neoplasms in Children
Children treated for neuroblastoma developed myeloid neoplasms with specific platinum chemotherapy-associated mutation signatures. -
Study Supports Full COVID-19 Vaccination for Cancer Patients
Cancer patients had a low rate of seropositivity after the first vaccine dose but not after the second dose. -
Pembrolizumab Improves Responses in Gastric, GEJ Cancers
The results led to another approved indication for pembrolizumab.
More Features
On-Treatment Ki-67: A Promising Prognostic Marker for Early Breast Cancer Management
Dr Alan Lyss reviews results from the high-risk cohort of the WSG-ADAPT HR+/HER2- trial.
Osimertinib Combinations as Second-Line Treatment in Non-Small Cell Lung Cancer: The Jury’s Still Out
Results from the BOOSTER trial add to data suggesting no benefit with osimertinib in combination over osimertinib alone.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Melanoma Brain Metastases: ‘Absolutely Treatable in 2021’
Experts outline treatment options and make recommendations.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
- Loading...
Loading...
Loading... 
Loading...